Loading...
Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer
An alternative or follow-up adjunct to conventional maximum tolerated dose (MTD) chemotherapy now in advanced phase III clinical trial assessment is metronomic chemotherapy—the close regular administration of low doses of drug with no prolonged breaks. A number of preclinical studies have shown metr...
Saved in:
| Published in: | Angiogenesis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540351/ https://ncbi.nlm.nih.gov/pubmed/24569856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-014-9422-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|